Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours

Open access

Abstract

As oxygen is essential for many metabolic pathways, tumour hypoxia may impair cancer cell proliferation 1-4. However, the limiting metabolites for proliferation under hypoxia and in tumours are unknown. Here, we assessed proliferation of a collection of cancer cells following inhibition of the mitochondrial electron transport chain (ETC), a major metabolic pathway requiring molecular oxygen 5. Sensitivity to ETC inhibition varied across cell lines, and subsequent metabolomic analysis uncovered aspartate availability as a major determinant of sensitivity. Cell lines least sensitive to ETC inhibition maintain aspartate levels by importing it through an aspartate/glutamate transporter, SLC1A3. Genetic or pharmacologic modulation of SLC1A3 activity markedly altered cancer cell sensitivity to ETC inhibitors. Interestingly, aspartate levels also decrease under low oxygen, and increasing aspartate import by SLC1A3 provides a competitive advantage to cancer cells at low oxygen levels and in tumour xenografts. Finally, aspartate levels in primary human tumours negatively correlate with the expression of hypoxia markers, suggesting that tumour hypoxia is sufficient to inhibit ETC and, consequently, aspartate synthesis in vivo. Therefore, aspartate may be a limiting metabolite for tumour growth, and aspartate availability could be targeted for cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41556-018-0118-z

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 445

Metadata

Authors
Garcia-Bermudez, J., Baudrier, L., La, K., Zhu, X. G., Fidelin, J., Sviderskiy, V. O., Papagiannakopoulos, T., Molina, H., Snuderl, M., Lewis, C. A., Possemato, R. L., & Birsoy, K.
Affiliations
  • Rockefeller University (US)
  • New York University (US)
  • Whitehead Institute for Biomedical Research (US)
Corresponding author
Birsoy, Kıvanç
Venue
Nature Cell Biology
Published
2018-06-25
Volume
20
Issue
7
Pages
775-781
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W2809675891
Cited by
442
References
40
Citations by year
2026: 43 · 2025: 50 · 2024: 64 · 2023: 62 · 2022: 61 · 2021: 49 · 2020: 63 · 2019: 38 · 2018: 12
FWCI
12.36
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (R37CA222504, K22CA201088, K22CA193660, R01CA227649, DP2CA228042, R01CA214948, R21CA198543)
  • National Institute of General Medical Sciences (T32GM007308)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
Keywords
aspartic acid, tumor hypoxia, tumor cell proliferation, GLAST, aspartate synthesis, hypoxia markers, tumor xenografts, metformin, cancer metabolism, metabolic targeting
MeSH terms
Tumor Hypoxia, Adult, Aged, Aged, 80 and over, Animals, Antineoplastic Agents, Aspartic Acid, Biological Transport, Energy Metabolism, Humans, Middle Aged, Mitochondria, Neoplasms, Time Factors, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Xenograft Model Antitumor Assays, Excitatory Amino Acid Transporter 1, Electron Transport Chain Complex Proteins, Cell Line, Tumor, Tumor Burden, Cell Proliferation, Metabolomics, Young Adult, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. https://app.cochat.ai/papers/10.1038/s41556-018-0118-z
The paper
Garcia-Bermudez, J., Baudrier, L., La, K., Zhu, X. G., Fidelin, J., Sviderskiy, V. O., Papagiannakopoulos, T., Molina, H., Snuderl, M., Lewis, C. A., Possemato, R. L., & Birsoy, K. (2018). Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nature Cell Biology. https://doi.org/10.1038/s41556-018-0118-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.